XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia

Leukemia and Lymphoma

Volumn 55, Issue 2, 2014, Pages 365-370

  Bǎnescu, Claudia ^a   Duicu, Carmen ^a   Trifa, Adrian P ^b   Dobreanu, Minodora ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Genetic polymorphisms; Myeloid leukemia; XRCC1 gene

Indexed keywords

ARGININE; XRCC1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLELE; ARTICLE; CANCER PROGNOSIS; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE DISEASE; ADULT; AGED; AMINO ACID SUBSTITUTION; ARGININE; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMINE; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SURVIVAL ANALYSIS; TRYPTOPHAN;

EID: 84904291894     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.802781     Document Type: Article

References (41)

1. Allan JM, Smith AG, Wheatley K, et al Genetic variation In XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood 2004;104:3872-3877. (Pubitemid 39620132)
2. Kuptsova N, Kopecky KJ, Godwin J, et al Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 2007;109:3936-3944. (Pubitemid 46641746)
3. Seedhouse C, Bainton R, Lewis M., et al The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 2002, 10:3761-3766. (Pubitemid 35303949)
4. Seedhouse C, Faulkner R, Ashraf N., et al Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res 2004, 10:2675-2680. (Pubitemid 38509141)
5. D'Andrea AD. Targeting DNA repair pathways in AML. Best Pract Res Clin Haematol 2010;23:469-473.
6. Caldecott KW. XRCC1 and DNA strand break repair. DNA Repair (Amst) 2003;2:955-969. (Pubitemid 37088158)
7. Chacko P, Rajan B, Joseph T., et al Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 2005;89:15-21. (Pubitemid 40228443)
8. Lindahl T, Wood RD Quality control by DNA repair. Science 1999;286:1897-1905. (Pubitemid 129515891)
9. Chen PL, Yeh KT, Tsai Y.Y., et al XRCC1, but not APE1 and hOGGl gene polymorphisms is a risk factor for pterygium. Mol 'Vis 2010; 16: 991-996.
10. Deligezer U, Akisik EE, Dalay N. Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia. Anticancer Res 2007;27:2453-2456. (Pubitemid 47228088)
11. Hu Z, Ma H, Chen F., et al XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005;14:1810-1818. (Pubitemid 40995099)
12. Hubbard TJ, Aken BL, Ayling S et al. Ensembl 2009. Nucleic Acids Res 2009;37:D690-D697.
13. Batar B, Güven M, Bariş S, et al. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2009;33:759-763.
14. García-Quispes W.A., Pérez-Machado G, Akdi A, et al. Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer. Mutat Res 2011;709-710:67-72.
15. Artac M, Bozcuk H, Pehlivan S, et al. The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens. J Cancer Res Clin Oncol 2010;136:803-809.
16. Huang Y, Li L, Yu L. XRCC1 Arg399Gln, Argl94Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 2009;24:331-339.
17. Dufloth RM, Costa S, Schmitt F., et al DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res 2005;4:771-782.
18. Gao W, Romkes M, Zhong S., et al Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncol Rep 2010;24:257-262.
19. Liu Y, Scheurer ME, El-Zein R, et al Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 2009;18:204-214.
20. Sreeja L, Syamala VS, Syamala V, et al Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol 2008;134:645-652. (Pubitemid 351502740)
21. Tae K, Lee HS, Park BJ, et al. Association of DNArepair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int J Cancer 2004;111:805-808. (Pubitemid 39062908)
22. Matsuo K, Hamajima N, Suzuki R., et al Lackof association between DNA base excision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphoma in Japan. Cancer Genet Cytogenet 2004;149:77-80. (Pubitemid 38177562)
23. Pakakasama S, Sirirat T, Kanchanachumpol S., et al Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;48:16-20. (Pubitemid 44871587)
24. Joseph T, Kusumakumary P, Chacko P., et al DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett 2005;217:17-24. (Pubitemid 39642862)
25. El-Din M., Raslan H, Abdel-Hamid S, et al Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia. Compar Clin Pathol 2012;12:505-513.
26. Seedhouse C, Russell N. Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia. Br J Haematol 2007;137:513-529. (Pubitemid 46817341)
27. Tefferi A, Vardiman JW Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008;22:14-22.
28. Vardiman JW, Thiele J, Arber D.A., et al The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937-951.
29. *2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia. Leuk Res 2007;31:947-953. (Pubitemid 46856725)
30. Wang Q, Wang AH, Tan H.S., et al Genetic polymorphisms of DNA repair genes and chromosomal damage in workers exposed to 1, 3-butadiene. Carcinogenesis 2010;31:858-863.
31. Wang R, Hu X, Zhou Y., et al XRCC1 Arg399Gln and Argl94Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis. Leuk Lymphoma 2013;54:153-159.
32. Meza-Espinoza J.P., Peralta-Leal V, Gutierrez-Angulo M, et al XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia. Genet Mol Res 2009;8: 1451-1458.
33. Shen M, Purdue M, Kricker A., et al Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica 2007;92:1180-1185. (Pubitemid 350144175)
34. Matullo G, Dunning AM, Guarrera S, et al DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006;27:997-1007.
35. Hung RJ, Hall J, Brennan P., et al Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 2005;162:925-942. (Pubitemid 41619464)
36. Turner TB, Yilmaz D, Tanrikut C., et al DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk Res 2010;34: 1275-1281.
37. El-Zein R., Monroy CM, Etzel C.J., et al Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk. Cancer 2009;115:1651-1659.
38. Liu J, Song B, Wang Z., et al DNA repair gene XRCC1 polymorphisms and non-Hodgkin lymphoma risk in a Chinese population. Cancer Genet Cytogenet 2009;191:67-72.
39. Smedby KE, Lindgren CM, Hjalgrim H, et al Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev 2006;15:258-265. (Pubitemid 43342172)
40. Yan L, Yanan D, Donglan S., et al Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma. Dis Esophagus 2009;22:396-401.
41. Skjelbred CF, Saebo M, Wallin H., et al Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer 2006;6:67.